Clinical anxiety and depression categories and comparative HADS scores for the XLA cohort versus UK male norms (median, IQR) (34) and UK male CF patients (mean, SD) (35)
| Clinical screening categories | Score | n (%) | 95% CI |
|---|---|---|---|
| HADS—anxiety (possible) | 8–10 | 6 (18.8%) | 8.9–35.3% |
| HADS—anxiety (probable) | ≥11 | 5 (15.6%) | 6.9–31.8% |
| HADS—depression (possible) | ≥8–10 | 2 (6.3%) | 1.7–19.9% |
| HADS—depression (probable) | 11 | 1 (3.1%) | 0.5–15.7% |
| Clinical screening categories | Score | 95% CI | |
|---|---|---|---|
| HADS—anxiety (possible) | 8–10 | 6 (18.8%) | 8.9–35.3% |
| HADS—anxiety (probable) | ≥11 | 5 (15.6%) | 6.9–31.8% |
| HADS—depression (possible) | ≥8–10 | 2 (6.3%) | 1.7–19.9% |
| HADS—depression (probable) | 11 | 1 (3.1%) | 0.5–15.7% |
| | XLA patients (n = 32) | UK male norms | P value | UK male CF patients | P value |
|---|---|---|---|---|---|
| HADS—Anxiety score | 5 (4, 9.5) | 5 (2, 8) | 0.147 | 5.7 (3.9) | 0.561 |
| HADS—Depression score | 2.5 (0.5, 5.5) | 3 (1, 6) | 0.873 | 3.4 (3.3) | 0.807 |
| | XLA patients ( | UK male norms | P value | UK male CF patients | P value |
|---|---|---|---|---|---|
| HADS—Anxiety score | 5 (4, 9.5) | 5 (2, 8) | 0.147 | 5.7 (3.9) | 0.561 |
| HADS—Depression score | 2.5 (0.5, 5.5) | 3 (1, 6) | 0.873 | 3.4 (3.3) | 0.807 |
| | Bronchiectasis | No bronchiectasis | P value | Bronchiectasis versus UK norms | Bronchiectasis versus CF patients |
|---|---|---|---|---|---|
| HADS—Anxiety score | 6 (5, 10) | 4 (1, 7) | 0.079 | 0.024 | 0.101 |
| HADS—Depression score | 4.5 (2, 7) | 0 (0, 2) | 0.003 | 0.066 | 0.122 |
| | Bronchiectasis | No bronchiectasis | P value | Bronchiectasis versus UK norms | Bronchiectasis versus CF patients |
|---|---|---|---|---|---|
| HADS—Anxiety score | 6 (5, 10) | 4 (1, 7) | 0.079 | 0.101 | |
| HADS—Depression score | 4.5 (2, 7) | 0 (0, 2) | 0.066 | 0.122 |
Values in italics are those that are statistically significant (P <0.05).